pioneer 2 semaglutide Efficacy and safety of once-daily oral 25 mg and 50 mg compared with 14 mg in adults with type diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial PIONEER 6: Oral Semaglutide Passes

These results suggest that these loci may indirectly influence migraine pathogenesis by regulating plasma protein levels at the gene level

The freeze-drying process already removed the water, so ice crystals cannot form

Most side effects are manageable and do not require discontinuation of the medication

While discussions at the Weight Management Summit highlighted gradually tapering the dose or increasing time between injections as strategy to manage patient withdrawal symptoms and reduce susceptibility to weight regain and sudden appetite spikes, the consensus was that sustaining metabolic change requires additional effort and assistance